Cefazolin 1000 mgr. – First Generation
Active ingredient and composition:
Each vial contains:
Sterile Cefazolin Sodium USP equivalent to Anhydrous Cefazolin 1000 mg.
For the treatment of the following infections due to susceptible organisms: respiratory tract infections, urinary tract infections, skin and skin structure infections, biliary tract infections, bone and joint infections, genital infections, septicemia, endocarditis. Perioperative Prophylaxis: The prophylactic administration of Cefazolin preoperatively, intraoperatively, and postoperatively may reduce the incidence of certain postoperative infections in patients undergoing surgical procedures which are classified as contaminated or potentially contaminated (e.g. vaginal hysterectomy, and cholecystectomy in high-risk patients such as those older than 70 years, with acute cholecystitis, obstructive jaundice, or common duct bile stones). The perioperative use of Cefazolin may also be effective in surgical patients in whom infection at the operative site would present a serious risk (e.g. during open-heart surgery and prosthetic arthroplasty). The prophylactic administration of Cefazolin should usually be discontinued within a 24-hour period after the surgical procedure. In surgery where the occurrence of infection may be particularly devastating (e.g. open-heart surgery and prosthetic arthroplasty), the prophylactic administration of Cefazolin may be continued for 3 to 5 days following the completion of surgery.
CEFAZOZEN-1000 and dextrose injection USP (Cefazolin and dextrose for injection) is contraindicated in patients who have known allergy to the cephalosporins group of antibiotics. Solution containing dextrose may be contraindicated in patients with hypersensitivity to corn products.
1000 mg vials of Cefazolin (as Cefazolin Sodium). Possibility to adapt packing and quantities to customer needs.
For intramuscular or intravenous administration.